Rising Star: Williams & Connolly's David Berl

Law360, New York (April 14, 2015, 8:59 PM EDT) -- Williams & Connolly LLP partner David Berl has secured patent victories for drugmakers such as MedImmune Inc. and Bayer HealthCare LLC, including a rare order requiring the U.S. Food and Drug Administration to withdraw approval of a generic drug, landing him on Law360's list of top intellectual property attorneys under 40.

The Law360 Rising Star, who is 39 and based in the firm's Washington, D.C., office, represented Bayer in a suit against the FDA after the agency approved Norbrook Laboratories Ltd.'s generic version of the cattle antibiotic Baytril, the flagship product of Bayer's animal health division.

The FDA approved the generic despite...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS